Plasma atherogenic indices are independent predictors of slow coronary flow

BMC Cardiovasc Disord. 2021 Dec 20;21(1):608. doi: 10.1186/s12872-021-02432-5.

Abstract

Background: Although the pathophysiology of coronary slow flow (CSF) has not been fully elucidated, emerging data increasingly support potential role for subclinical diffuse atherosclerosis in the etiology of CSF. We aimed to investigate relationship between atherogenic indices and CSF.

Methods: 130 patients with CSF diagnosed according to Thrombolysis in Myocardial Infarction (TIMI)-frame count (TFC) method and 130 controls who had normal coronary flow (NCF) were included in this retrospective study. Atherogenic indices (atherogenic index of plasma [AIP], Castelli risk indices I and II [CRI-I and II]) were calculated using conventional lipid parameters.

Results: The logistic regression analyses demonstrated that AIP (OR, 5.463; 95% confidence interval [CI], 1.357-21.991; p = 0.017) and CRI-II (OR, 1.624; 95% CI, 1.138-2.319; p = 0.008) were independent predictors of CSF. Receiver operating characteristic analysis showed that the optimal cutoff value to predict the occurrence of CSF was 0.66 for AIP (sensitivity, 59%; specificity, 73%; area under curve [AUC], 0.695; p < 0.001) and 3.27 for CRI-II (sensitivity, 60%; specificity, 79%; AUC, 0.726; p < 0.001).

Conclusions: AIP and CRI-II levels were independent predictors of CSF. Prospective studies in larger cohorts of patients may elucidate the role of atherogenic dyslipidemia in the pathophysiology of CSF.

Keywords: Atherogenic index of plasma; Cardiovascular risk factors; Castelli risk indices; Coronary artery; Coronary intervention; Coronary slow flow; Frame count.

Publication types

  • Observational Study

MeSH terms

  • Biomarkers / blood
  • Blood Flow Velocity
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / etiology
  • Coronary Circulation*
  • Dyslipidemias / blood*
  • Dyslipidemias / complications
  • Dyslipidemias / diagnosis
  • Female
  • Heart Disease Risk Factors
  • Humans
  • Lipids / blood*
  • Male
  • Middle Aged
  • No-Reflow Phenomenon / diagnostic imaging
  • No-Reflow Phenomenon / etiology*
  • No-Reflow Phenomenon / physiopathology
  • Predictive Value of Tests
  • Retrospective Studies
  • Risk Assessment

Substances

  • Biomarkers
  • Lipids